MusclePharm Corp
OTC:MSLPQ
MusclePharm Corp
OTC:MSLPQ
Price:
0.0012
USD
Market Closed
Market Cap:
$34.3
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
MusclePharm Corp
OTC:MSLPQ
|
US |
|
Lamb Weston Holdings Inc
NYSE:LW
|
US |
|
W
|
Western Union Co
XETRA:W3U
|
US |
|
Kyung-In Synthetic Corp
KRX:012610
|
KR |
|
J
|
J Sainsbury PLC
DUS:SUY1
|
UK |
|
Landix Inc
TSE:2981
|
JP |
Balance Sheet
Balance Sheet Decomposition
MusclePharm Corp
MusclePharm Corp
Balance Sheet Decomposition is not available for
MusclePharm Corp
MusclePharm Corp
Balance Sheet
MusclePharm Corp
MusclePharm Corp
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
2
|
2
|
1
|
|
| Cash |
2
|
2
|
1
|
|
| Total Receivables |
5
|
7
|
6
|
|
| Accounts Receivables |
5
|
7
|
6
|
|
| Other Receivables |
0
|
0
|
0
|
|
| Inventory |
5
|
1
|
2
|
|
| Other Current Assets |
1
|
1
|
2
|
|
| Total Current Assets |
12
|
12
|
11
|
|
| PP&E Net |
1
|
0
|
0
|
|
| PP&E Gross |
1
|
0
|
0
|
|
| Accumulated Depreciation |
4
|
0
|
0
|
|
| Intangible Assets |
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Total Assets |
15
N/A
|
13
-11%
|
11
-14%
|
|
| Liabilities | ||||
| Accounts Payable |
26
|
15
|
18
|
|
| Accrued Liabilities |
5
|
7
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
10
|
11
|
17
|
|
| Total Current Liabilities |
42
|
32
|
41
|
|
| Long-Term Debt |
0
|
1
|
0
|
|
| Other Liabilities |
1
|
4
|
2
|
|
| Total Liabilities |
42
N/A
|
37
-12%
|
43
+16%
|
|
| Equity | ||||
| Common Stock |
0
|
0
|
0
|
|
| Retained Earnings |
196
|
193
|
206
|
|
| Additional Paid In Capital |
178
|
178
|
183
|
|
| Treasury Stock |
10
|
10
|
10
|
|
| Total Equity |
28
N/A
|
24
+13%
|
32
-32%
|
|
| Total Liabilities & Equity |
15
N/A
|
13
-11%
|
11
-14%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
33
|
33
|
33
|
|
Switch to:
Switch to:
See Also
Discover More
